CBD vs melatonin for sleep: UK 2026 educational comparison

Critical regulatory distinction UK

Critical regulatory distinction UK + sustained UK consumer protection + UK FSA Novel Food framework + UK NHS framework. Melatonin in UK = prescription-only medicine (POM): regulated by MHRA (Medicines and Healthcare products Regulatory Authority); not available over-the-counter unlike US + many other countries; prescribed by GP only + sustained UK consumer protection. NHS prescription melatonin uses: over-55s with insomnia (Circadin brand modified-release) + circadian rhythm disorders + jet lag + specific paediatric sleep conditions (autism + ADHD + neurodevelopmental conditions where other treatments unsuccessful) + sustained UK NHS framework. Why melatonin is POM in UK: clinical effects + dosing requirements + drug interactions + regulatory framework + sustained UK consumer protection; MHRA decision. CBD edibles = food supplements: regulated by FSA (Food Standards Agency) Novel Food framework since 31 March 2021; not medicines; cannot make medical claims; sustained UK consumer awareness. Why CBD is not classified as medicine: insufficient regulatory dossiers for medical approval + variable products + sustained UK regulatory framework; only Epidyolex (CBD prescription medicine for specific epilepsy) MHRA-approved. Sativex (nabiximols): CBD + THC prescription-only medicine MHRA-approved for specific MS spasticity; not for sleep + critically different from over-the-counter CBD edibles. Critical comparison limitations: cannot make direct efficacy comparison between melatonin (medicine) + CBD edibles (food supplement); different regulatory frameworks + different research bases + neither approved for general insomnia treatment in UK + sustained UK consumer awareness. NICE evidence-based guidance for chronic insomnia: CBT-I first-line treatment; sleep medications (benzodiazepines + Z-drugs) only short-term if needed; melatonin specific indications; doesn't recommend CBD; sustained UK NHS framework. NHS support resources priority over CBD or melatonin self-prescription considerations: NHS 999: emergency sleep-related crises + sustained UK NHS framework + sustained UK consumer protection. NHS 111: non-emergency sleep support + sustained UK NHS framework. GP appointment: insomnia diagnosis + treatment plan + appropriate prescription if needed + sleep clinic referral + sustained UK NHS framework. NHS Talking Therapies (CBT-I): NICE first-line + self-referral or GP referral + sustained UK NHS framework + sustained UK consumer protection. NHS sleep clinics: specialist sleep care + sustained UK NHS framework. Samaritans 116 123: free 24/7 emotional support + sleep + mental health linked + sustained UK consumer protection. Mind UK 0300 123 3393: mental health + sustained UK consumer protection. The Sleep Charity: information + sustained UK consumer protection. Don't buy melatonin from non-UK sources online: bypass MHRA regulation + counterfeit risk + variable potency + safety concerns + sustained UK consumer protection. UK Trading Standards investigations: misleading medical claims about CBD + non-compliant products including unauthorised melatonin sales + sustained UK consumer protection. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): cannot sell melatonin as food supplement (POM only); cannot make medical claims about CBD; provide UK Novel Food authorised CBD products + lab testing certificates + UK 18+ age verification + sustained UK consumer protection. UK Novel Food regulated CBD: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality. UK FSA compliant. CBD is a food supplement not a medicine. Melatonin is prescription-only medicine in UK.

Melatonin overview prescription medicine

Melatonin overview as UK prescription-only medicine + sustained UK NHS framework + sustained UK consumer protection. Melatonin = endogenous hormone: produced by pineal gland + regulates circadian rhythm + sleep-wake cycle + secreted during darkness; sustained UK consumer awareness. Synthetic melatonin = prescription medicine in UK: regulated by MHRA + Circadin (modified-release) + Slenyto (paediatric) brands + GP-prescribed only + sustained UK consumer protection. Specific NHS melatonin indications: over-55s with insomnia (Circadin) + circadian rhythm disorders (delayed sleep phase syndrome + non-24-hour sleep-wake disorder + shift work disorder) + jet lag + specific paediatric sleep conditions (autism + ADHD + neurodevelopmental conditions where other treatments unsuccessful) + sustained UK NHS framework. NHS doesn't recommend melatonin for general insomnia: not first-line; CBT-I + sleep hygiene preferred + sustained UK NHS framework. Mechanism preliminary understanding: melatonin receptors (MT1 + MT2) + circadian rhythm regulation + theoretical sleep latency reduction; specific indications evidence-based. Side effects: typically well tolerated + headaches + drowsiness + dizziness + nausea + can affect blood pressure; sustained UK consumer awareness. Drug interactions: warfarin + immunosuppressants + sedatives + many others; metabolised by CYP1A2 enzyme; sustained UK consumer protection. Caution in: pregnancy + breastfeeding + autoimmune conditions + epilepsy + liver disease + always consult GP + sustained UK consumer protection. Why melatonin is POM in UK (not OTC): clinical effects + drug interactions + dosing complexity + safety regulation + sustained UK consumer protection; MHRA decision. Compared to US (OTC) + many countries: UK regulatory framework more conservative + sustained UK consumer protection. Don't buy melatonin from non-UK sources: bypass MHRA regulation + counterfeit risk + variable potency + safety concerns + sustained UK consumer protection. If interested in melatonin: speak to GP for prescription if appropriate + sustained UK NHS framework + sustained UK consumer protection. NHS support resources priority: GP appointment + NHS 111 + NHS Talking Therapies (CBT-I) + NHS sleep clinics + Samaritans 116 123 + Mind UK 0300 123 3393 + The Sleep Charity + sustained UK consumer protection. NICE evidence-based guidance: CBT-I first-line + sleep hygiene + melatonin specific indications only + sustained UK NHS framework. Drug interactions with sleep medications: melatonin + CBD + sedatives amplification risk; always consult GP + sustained UK consumer protection. Sleep hygiene fundamentals priority: consistent sleep schedule + cool dark quiet bedroom (16-18°C) + reduced screen time before bed + avoid caffeine afternoon + evening + avoid alcohol close to bedtime + regular exercise + balanced diet + manage stress + reduce naps + sustained UK NHS framework. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): cannot sell melatonin (POM only) + can sell UK Novel Food authorised CBD products + lab testing certificates + UK 18+ age verification + cannot make medical claims + sustained UK consumer protection. UK Novel Food regulated CBD: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality. Pregnancy + breastfeeding: FSA precautionary advice for CBD + melatonin caution + sustained UK consumer protection. Underlying health conditions: GP consultation essential. UK FSA compliant. CBD is a food supplement not a medicine. Melatonin is prescription-only medicine in UK.

CBD edibles overview food supplement

CBD edibles overview as UK food supplement + sustained UK FSA Novel Food framework + sustained UK consumer protection + UK Trading Standards quality. CBD edibles = food supplements: regulated by FSA (Food Standards Agency) Novel Food framework since 31 March 2021; not medicines; cannot make medical claims; sustained UK consumer awareness. FSA 70mg/day precautionary recommendation: cumulative across all CBD products + sustained UK consumer protection. UK Misuse of Drugs Regulations: 1mg THC max per container + sustained UK consumer protection. UK 18+ verification: established UK retailers verify age + never sold to under-18s + sustained UK consumer protection. Why CBD is not classified as medicine in UK: insufficient regulatory dossiers for medical approval + variable products + sustained UK regulatory framework. Theoretical CBD sleep mechanisms preliminary research: Endocannabinoid system modulation: theoretical relevance + sustained scientific research interest. 5-HT1A serotonin receptor interaction: serotonin involved in sleep regulation + sustained scientific research interest; not conclusive. Theoretical anxiety modulation: anxiety frequent cause of insomnia + sustained scientific research interest; not conclusive. Theoretical sleep latency effects: time to fall asleep; preliminary studies + variable results + sustained UK consumer awareness. Adenosine receptor interaction: adenosine involved in sleep pressure + sustained scientific research interest. Multi-target nature: CBD effects thought to result from multiple receptor interactions + sustained UK consumer awareness; complicates research. Methodological limitations: small studies + variable CBD products + variable doses + heterogeneous populations + short duration + lack of large randomised controlled trials + sustained UK consumer awareness; insufficient for clinical recommendations. Variable dose-response: some studies suggest different effects at different doses (low alerting + high sedating); not conclusive + sustained UK consumer awareness. Animal vs human studies: much CBD sleep research conducted in animals; human evidence limited + sustained UK consumer awareness. Don't make medical claims about CBD and sleep: scientific research preliminary + not conclusive + CBD edibles cannot diagnose + treat + cure + prevent any condition + sustained UK FSA Novel Food framework + UK Trading Standards quality. UK Trading Standards investigations: misleading sleep claims + non-compliant products + sustained UK consumer protection. NICE evidence-based guidelines for insomnia: don't recommend CBD; recommend CBT-I first-line + sleep hygiene + medications if needed short-term + sustained UK NHS framework. Don't use CBD as substitute for evidence-based insomnia treatment: persistent insomnia requires GP consultation + sustained UK NHS framework + sustained UK consumer protection. Common CBD edible side effects: drowsiness + dry mouth + diarrhoea + reduced appetite + fatigue + headaches; sustained UK consumer awareness. Drug interactions critical: CBD inhibits CYP3A4 + CYP2C19 enzymes; many medications affected; always consult GP + sustained UK consumer protection. NHS support resources priority over CBD considerations: GP appointment + NHS 111 + NHS Talking Therapies (CBT-I) + NHS sleep clinics + Samaritans 116 123 + Mind UK 0300 123 3393 + The Sleep Charity + sustained UK consumer protection. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): provide UK Novel Food authorised products + counterfeit prevention + UK 18+ age verification + lab testing certificates + cannot make medical claims + refer customers to GP for medical questions + sustained UK consumer protection. UK Novel Food regulated: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality. Pregnancy + breastfeeding: FSA precautionary advice + sustained UK consumer protection. Underlying health conditions: GP consultation essential. UK FSA compliant. CBD is a food supplement not a medicine. Melatonin is prescription-only medicine in UK.

Drug interactions both CBD + melatonin critical

Drug interactions critical considerations + sustained UK consumer protection + UK FSA Novel Food framework + sustained UK NHS framework. CBD drug interactions critical: CBD inhibits CYP3A4 + CYP2C19 liver enzymes; many medications affected; always consult GP + sustained UK consumer protection. Melatonin drug interactions: metabolised by CYP1A2 enzyme; warfarin + immunosuppressants + sedatives + diabetes medications + many others; always consult GP + sustained UK consumer protection. If considering CBD + melatonin together: do NOT self-medicate; melatonin is POM in UK requires GP prescription; always consult GP + sustained UK consumer protection. Sleep medication amplification critical: benzodiazepines (temazepam + diazepam + lorazepam) + Z-drugs (zopiclone + zolpidem + zaleplon) + sedating antihistamines (diphenhydramine Nytol + promethazine Phenergan) + opioids + alcohol + amplification risk with both CBD + melatonin; always consult GP + sustained UK consumer protection. Antidepressants: SSRIs + SNRIs + tricyclics + serotonin syndrome theoretical risk; CBD + melatonin caution; always consult GP + sustained UK consumer protection. Antihypertensives: blood pressure medications; CBD + melatonin may affect blood pressure; always consult GP + sustained UK consumer protection. Anti-seizure medications: critical CYP interactions with CBD; always consult GP + epilepsy specialist + sustained UK consumer protection. Blood thinners critical: warfarin + DOACs (apixaban + rivaroxaban); CBD + melatonin both affect warfarin; always consult GP + regular monitoring + sustained UK consumer protection. Diabetes medications: melatonin may affect blood sugar; CBD interactions; always consult GP + diabetes specialist + sustained UK consumer protection. Immunosuppressants critical: melatonin theoretical immune effects; CBD CYP interactions; always consult specialist + sustained UK consumer protection. Hormonal contraceptives: CBD CYP3A4 interactions theoretical; always consult GP + sustained UK consumer protection. Many other medications affected: not exhaustive list + always consult GP + sustained UK consumer protection. Never stop prescribed medications based on CBD or melatonin use: dangerous + always consult GP + sustained UK consumer protection. Always tell GP about CBD use: if taking medications + always consult GP + sustained UK consumer protection. NHS pharmacist consultation: free NHS pharmacist consultation for medication queries + sustained UK NHS framework + sustained UK consumer protection. BNF (British National Formulary): prescribers reference for medication interactions + GP + pharmacist resource + sustained UK NHS framework. NHS support resources priority: GP appointment + NHS 111 + NHS Talking Therapies (CBT-I) + NHS sleep clinics + Samaritans 116 123 + Mind UK 0300 123 3393 + sustained UK consumer protection. Don't use CBD or self-prescribe melatonin as substitute for sleep treatment: prescribed medications + CBT-I evidence-based + GP-managed + sustained UK NHS framework + sustained UK consumer protection. UK Novel Food regulated CBD: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality. Melatonin = prescription-only medicine UK: MHRA-regulated + GP-prescribed only + sustained UK consumer protection. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): cannot sell melatonin (POM only) + can sell UK Novel Food authorised CBD + cannot make medical claims + sustained UK consumer protection. UK Trading Standards investigations: misleading sleep claims + non-compliant products + unauthorised melatonin sales + sustained UK consumer protection. Pregnancy + breastfeeding: FSA precautionary advice for CBD + melatonin caution + sustained UK consumer protection. Underlying health conditions: GP consultation essential. UK 18+ verification CBD: established UK retailers verify age + never sold to under-18s + sustained UK consumer protection. UK consumer rights: faulty products = retailer replacement obligation under Consumer Rights Act 2015. UK FSA compliant. CBD is a food supplement not a medicine. Melatonin is prescription-only medicine in UK + cannot diagnose + treat + cure + prevent any condition.

When to seek help + GP route for sleep

When to seek help + GP route for sleep priority over CBD or self-prescribed melatonin considerations + sustained UK NHS framework + sustained UK consumer protection. Seek help if persistent sleep problems: difficulty falling asleep + maintaining sleep + early waking + 3+ nights per week for 3+ months + impact on daytime function + mood + concentration + sustained UK NHS framework. NHS 999 if: severe acute breathing problems during sleep + sleep-related medical emergency + sustained UK NHS framework + sustained UK consumer protection. NHS 111: non-emergency sleep problem support + sustained UK NHS framework. GP appointment: persistent insomnia diagnosis + treatment plan + appropriate prescription (including melatonin if indicated) + sleep clinic referral + sustained UK NHS framework. NHS Talking Therapies (CBT-I): NICE first-line treatment for chronic insomnia + self-referral or GP referral + sustained UK NHS framework + sustained UK consumer protection. NHS sleep clinics: specialist sleep care + sleep studies + sustained UK NHS framework. Samaritans 116 123: free 24/7 emotional support + sleep + mental health linked + sustained UK consumer protection. Mind UK 0300 123 3393: mental health support + sustained UK consumer protection. The Sleep Charity: sleep information + support + sustained UK consumer protection. British Sleep Society: sleep professional information + sustained UK consumer protection. Don't self-prescribe melatonin from non-UK sources: bypass MHRA regulation + counterfeit risk + variable potency + safety concerns; speak to GP for proper prescription if appropriate + sustained UK consumer protection. Don't self-treat persistent insomnia with CBD: requires evidence-based treatment + GP consultation essential + sustained UK NHS framework + sustained UK consumer protection. CBD is a food supplement not a medicine: cannot diagnose + treat + cure + prevent any condition + sustained UK FSA Novel Food framework + UK Trading Standards quality. Melatonin is prescription-only medicine in UK: MHRA-regulated + GP-prescribed only + sustained UK consumer protection; specific NHS indications. CBD products are not approved medical treatments in UK: regardless of marketing claims + sustained UK consumer protection. UK Trading Standards investigations: misleading sleep claims about CBD + unauthorised melatonin sales + non-compliant products + sustained UK consumer protection. Drug interactions critical with sleep medications: CBD interacts with CYP3A4 + CYP2C19 enzymes; melatonin metabolised by CYP1A2; benzodiazepines + Z-drugs + sedating antihistamines + alcohol amplification risk with both; many other sedating medications affected; never stop prescribed medication based on CBD or melatonin use + always consult GP + sustained UK consumer protection. Sleep hygiene fundamentals priority: consistent sleep schedule + cool dark quiet bedroom (16-18°C) + comfortable mattress + reduced screen time before bed + avoid caffeine afternoon + evening + avoid alcohol close to bedtime + regular exercise (not too late) + balanced diet + manage stress + reduce naps + sustained UK NHS framework + sustained UK consumer wellbeing. UK Novel Food regulated CBD: FSA authorisation since 31 March 2021 + 1mg THC max + sustained UK Trading Standards quality + UK 18+ verification. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): cannot sell melatonin (POM only) + can sell UK Novel Food authorised CBD + cannot make medical claims + provide product information + lab testing certificates + sustained UK consumer protection. Pregnancy + breastfeeding: FSA precautionary advice for CBD + melatonin caution + sustained UK consumer protection. UK consumer rights: faulty products = retailer replacement obligation under Consumer Rights Act 2015. UK FSA compliant. CBD is a food supplement not a medicine. Melatonin is prescription-only medicine in UK + cannot diagnose + treat + cure + prevent any condition.

Critical regulatory distinction: melatonin is a prescription-only medicine in the UK + CBD edibles are food supplements not medicines + neither can diagnose + treat + cure + prevent any condition. Persistent insomnia is a medical condition requiring professional medical care. Please speak to your GP, NHS 111, or NHS Talking Therapies for CBT-I if struggling with insomnia. UK Novel Food regulated + 1mg THC max + UK 18+ verification + within FSA 70mg/day recommendation. Always consult GP if taking medication or pregnant or breastfeeding. CBD is a food supplement not a medicine. To pick up your CBD edibles see the CBD edibles collection.